PNC Financial Services Group’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,911
Closed -$1.19M 4738
2021
Q3
$1.19M Sell
6,911
-23
-0.3% -$3.95K ﹤0.01% 1113
2021
Q2
$870K Sell
6,934
-587
-8% -$73.7K ﹤0.01% 1270
2021
Q1
$1.02M Sell
7,521
-123
-2% -$16.7K ﹤0.01% 1148
2020
Q4
$979K Sell
7,644
-196
-3% -$25.1K ﹤0.01% 1137
2020
Q3
$882K Buy
7,840
+1,354
+21% +$152K ﹤0.01% 1094
2020
Q2
$618K Buy
6,486
+355
+6% +$33.8K ﹤0.01% 1257
2020
Q1
$551K Sell
6,131
-2,487
-29% -$224K ﹤0.01% 1242
2019
Q4
$458K Buy
8,618
+732
+9% +$38.9K ﹤0.01% 1534
2019
Q3
$313K Buy
7,886
+240
+3% +$9.53K ﹤0.01% 1871
2019
Q2
$314K Buy
7,646
+366
+5% +$15K ﹤0.01% 1906
2019
Q1
$339K Sell
7,280
-160
-2% -$7.45K ﹤0.01% 1844
2018
Q4
$323K Buy
7,440
+1,460
+24% +$63.4K ﹤0.01% 1777
2018
Q3
$343K Buy
5,980
+1,596
+36% +$91.5K ﹤0.01% 1882
2018
Q2
$213K Sell
4,384
-126,735
-97% -$6.16M ﹤0.01% 2145
2018
Q1
$5.13M Buy
131,119
+122,907
+1,497% +$4.81M 0.01% 724
2017
Q4
$348K Buy
8,212
+132
+2% +$5.59K ﹤0.01% 1854
2017
Q3
$302K Sell
8,080
-380
-4% -$14.2K ﹤0.01% 1911
2017
Q2
$258K Buy
8,460
+3,100
+58% +$94.5K ﹤0.01% 1998
2017
Q1
$142K Sell
5,360
-400
-7% -$10.6K ﹤0.01% 2299
2016
Q4
$146K Buy
5,760
+740
+15% +$18.8K ﹤0.01% 2269
2016
Q3
$182K Sell
5,020
-35
-0.7% -$1.27K ﹤0.01% 2141
2016
Q2
$172K Buy
5,055
+4,935
+4,113% +$168K ﹤0.01% 2182
2016
Q1
$3K Buy
120
+4
+3% +$100 ﹤0.01% 4100
2015
Q4
$6K Hold
116
﹤0.01% 3819
2015
Q3
$3K Buy
116
+4
+4% +$103 ﹤0.01% 4192
2015
Q2
$4K Buy
112
+51
+84% +$1.82K ﹤0.01% 4202
2015
Q1
$2K Buy
+61
New +$2K ﹤0.01% 4344